Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
EraGen Biosciences
Two technologies used to study SARS
July 30th, 2003
EraGen Biosciences announced that two technologies, Gene-Code and the Master Catalog have proven to work effectively in the study of the SARS virus. "The EraGen Gene-Code SARS Assay has been shown to detect live virus in the hands of international government agencies. This product evaluation confirms that the SARS Assay, developed in Madison, Wisconsin performs well and detects real virus in the hands of health agency researchers," commented Gary Madsen, PhD, chief technical officer for EraGen. Also from EraGen, the Master Catalog Evolutionary Analysis System provides a unique genomic landscape of the virus. The Master Catalog has provided...
Source: Biotech Week (2003-07-30)
|
